vs
Side-by-side financial comparison of Armour Residential REIT, Inc. (ARR) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
Armour Residential REIT, Inc. is the larger business by last-quarter revenue ($50.4M vs $47.7M, roughly 1.1× IRONWOOD PHARMACEUTICALS INC). Armour Residential REIT, Inc. runs the higher net margin — 420.2% vs -4.8%, a 425.0% gap on every dollar of revenue. On growth, Armour Residential REIT, Inc. posted the faster year-over-year revenue change (297.9% vs -47.3%). Over the past eight quarters, Armour Residential REIT, Inc.'s revenue compounded faster (108.0% CAGR vs -20.2%).
Armour Residential REIT, Inc. is a U.S.-based real estate investment trust that primarily invests in agency residential mortgage-backed securities guaranteed by U.S. government-sponsored entities. It focuses on generating consistent long-term net income for shareholders via strategic asset management and active interest rate risk mitigation.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
ARR vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $50.4M | $47.7M |
| Net Profit | $211.7M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | — | 14.3% |
| Net Margin | 420.2% | -4.8% |
| Revenue YoY | 297.9% | -47.3% |
| Net Profit YoY | 555.9% | -200.9% |
| EPS (diluted) | $2.43 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $50.4M | $47.7M | ||
| Q3 25 | $38.5M | $122.1M | ||
| Q2 25 | $33.1M | $85.2M | ||
| Q1 25 | $36.3M | $41.1M | ||
| Q4 24 | $12.7M | $90.5M | ||
| Q3 24 | — | $91.6M | ||
| Q2 24 | $7.0M | $94.4M | ||
| Q1 24 | — | $74.9M |
| Q4 25 | $211.7M | $-2.3M | ||
| Q3 25 | $159.3M | $40.1M | ||
| Q2 25 | $-75.6M | $23.6M | ||
| Q1 25 | $27.3M | $-37.4M | ||
| Q4 24 | $-46.4M | $2.3M | ||
| Q3 24 | — | $3.6M | ||
| Q2 24 | $-48.4M | $-860.0K | ||
| Q1 24 | — | $-4.2M |
| Q4 25 | — | 14.3% | ||
| Q3 25 | — | 61.8% | ||
| Q2 25 | — | 53.2% | ||
| Q1 25 | — | -70.7% | ||
| Q4 24 | — | 34.8% | ||
| Q3 24 | — | 28.0% | ||
| Q2 24 | — | 26.5% | ||
| Q1 24 | — | 14.7% |
| Q4 25 | 420.2% | -4.8% | ||
| Q3 25 | 413.5% | 32.8% | ||
| Q2 25 | -228.4% | 27.7% | ||
| Q1 25 | 75.2% | -90.9% | ||
| Q4 24 | -366.8% | 2.5% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | -693.8% | -0.9% | ||
| Q1 24 | — | -5.6% |
| Q4 25 | $2.43 | $0.01 | ||
| Q3 25 | $1.49 | $0.23 | ||
| Q2 25 | $-0.94 | $0.14 | ||
| Q1 25 | $0.32 | $-0.23 | ||
| Q4 24 | $-0.91 | $0.03 | ||
| Q3 24 | — | $0.02 | ||
| Q2 24 | $-1.05 | $-0.01 | ||
| Q1 24 | — | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.3M | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.3B | $-261.8M |
| Total Assets | $21.0B | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.3M | $215.5M | ||
| Q3 25 | $44.2M | $140.4M | ||
| Q2 25 | $141.2M | $92.9M | ||
| Q1 25 | $49.1M | $108.5M | ||
| Q4 24 | $68.0M | $88.6M | ||
| Q3 24 | — | $88.2M | ||
| Q2 24 | $126.6M | $105.5M | ||
| Q1 24 | — | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $2.3B | $-261.8M | ||
| Q3 25 | $2.1B | $-264.2M | ||
| Q2 25 | $1.7B | $-308.2M | ||
| Q1 25 | $1.7B | $-334.1M | ||
| Q4 24 | $1.4B | $-301.3M | ||
| Q3 24 | — | $-311.3M | ||
| Q2 24 | $1.2B | $-321.7M | ||
| Q1 24 | — | $-330.5M |
| Q4 25 | $21.0B | $396.9M | ||
| Q3 25 | $19.4B | $396.1M | ||
| Q2 25 | $16.2B | $342.9M | ||
| Q1 25 | $15.5B | $327.2M | ||
| Q4 24 | $13.5B | $350.9M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | $10.1B | $395.6M | ||
| Q1 24 | — | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $124.2M | $74.6M |
| Free Cash FlowOCF − Capex | — | $74.6M |
| FCF MarginFCF / Revenue | — | 156.3% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 0.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $124.2M | $74.6M | ||
| Q3 25 | $-37.8M | $47.6M | ||
| Q2 25 | $25.0M | $-15.1M | ||
| Q1 25 | $101.5M | $20.0M | ||
| Q4 24 | $261.5M | $15.2M | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | $27.1M | $33.5M | ||
| Q1 24 | — | $45.0M |
| Q4 25 | — | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | — | $-15.1M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | — | $33.4M | ||
| Q1 24 | — | $44.9M |
| Q4 25 | — | 156.3% | ||
| Q3 25 | — | 39.0% | ||
| Q2 25 | — | -17.7% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | 35.4% | ||
| Q1 24 | — | 60.0% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | 0.59× | — | ||
| Q3 25 | -0.24× | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | 3.71× | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
